ROYAL BANK OF CANADA - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 26 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$1,000513
+1.6%
0.00%
Q4 2017$0
-100.0%
5050.0%0.00%
Q3 2017$1,0000.0%505
+1.0%
0.00%
Q2 2017$1,0000.0%5000.0%0.00%
Q1 2017$1,0000.0%5000.0%0.00%
Q4 2016$1,0000.0%5000.0%0.00%
Q3 2016$1,0000.0%5000.0%0.00%
Q2 2016$1,0005000.0%0.00%
Q1 2016$0
-100.0%
500
-16.7%
0.00%
Q4 2015$2,000600
+500.0%
0.00%
Q3 2015$0
-100.0%
100
-66.7%
0.00%
Q2 2015$1,000300
+1664.7%
0.00%
Q1 2015$0170.00%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 4,841,591$78,579,00013.93%
Flagship Ventures 2007 General Partner LLC 1,907,008$30,951,00013.58%
Broadfin Capital, LLC 861,933$13,989,0001.36%
NJ State Employees Deferred Compensation Plan 25,000$406,0000.08%
SECTORAL ASSET MANAGEMENT INC 50,000$812,0000.03%
TCW GROUP INC 105,550$1,713,0000.01%
FRANKLIN RESOURCES INC 938,100$15,225,0000.01%
State of New Jersey Common Pension Fund A 75,000$1,217,0000.01%
FMR LLC 1,614,715$26,206,0000.00%
PRINCIPAL FINANCIAL GROUP INC 95,300$1,547,0000.00%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders